However, for patients with slightly elevated PSA levels, multiparametric MRI scans that are not covered by health insurance can be a financial burden to the patient, and there are cases where it is difficult to distinguish between prostate cancer and normal prostate tissue even though standardized interpretation systems, such as PI-RADS version 2, have been adapted. The gene discussed is KLK3; the disease is prostate cancer.